DUBLIN, Nov. 3, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Pediatric Vaccine Market 2014-2018" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
Pediatric vaccines are used for the immunization of children and adolescents against various infectious diseases, such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the US FDA, pediatric age ranges are classified as newborn, infant, child, and adolescent, ranging from birth to 21 years. However, the EMA classifies pediatric age range from birth to 18 years.
The analysts forecast the Global Pediatric Vaccine market to grow at a CAGR of 10.25 percent over the period 2013-2018.
This report covers the present scenario and the growth prospects of the Global Pediatric Vaccine market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various approved vaccines.
The report, the Global Pediatric Vaccine Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Pediatric Vaccine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
One key trend emerging in this market is the strategic alliances of the vendors in the market, resulting in consolidation to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company.
According to the report, the major driving factor of the market is the inclusion of various pediatric vaccines in the national immunization schedule of many countries. This helps by virtue of increase in the consumption of vaccines in the market, thereby boosting growth.
Further, the report states that the inadequate vaccine coverage in the world is a major challenge to the growth of the market. It results in the vaccines in the market being out of reach of the patients, which restrains growth.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Market Segmentation by Route of Administration
08. Market Segmentation by Product Type
09. Geographical Segmentation
10. Key Leading Countries
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
19. Key Vendor Analysis
20. Other Reports in this Series
Companies Mentioned:
- AstraZeneca
- Bavarian Nordic
- Baxter
- Bharat Biotech
- Bharat Immunologicals and Biologicals
- Bio Med
- Crucell
- Dynavax Technologies
- GlaxoSmithKline
- Indian Immunologicals
- Janssen
- Kaketsuken
- LG Life Sciences
- Lupin
- Merck
- Mitsubishi Tanabe Pharma
- Novartis
- Nuron
- Panacea Biotec
- Pfizer
- S K Chemicals
- Sanofi
- Serum Institute of India
- Shenzhen Kangtai Biological Products
- Sinovac Biotech
- Takeda Pharmaceutical
- Valeant Pharmaceuticals
- Zydus Cadila
- bioCSL
For more information visit http://www.researchandmarkets.com/research/8nwbb8/global_pediatric
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
